1st Circ. Won't Rehear Novartis Gleevec Antitrust Suit
A First Circuit panel on Thursday said it wouldn't reconsider its decision to uphold the dismissal of an antitrust suit accusing Novartis Pharmaceuticals Corp. of delaying a generic version of its...To view the full article, register now.
Already a subscriber? Click here to view full article